TY - JOUR
T1 - Role of molecular imaging in the management of patients affected by inflammatory bowel disease
T2 - State-of-the-art
AU - Caobelli, Federico
AU - Evangelista, Laura
AU - Quartuccio, Natale
AU - Familiari, Demetrio
AU - Altini, Corinna
AU - Castello, Angelo
AU - Cucinotta, Mariapaola
AU - Di Dato, Rossella
AU - Ferrari, Cristina
AU - Kokomani, Aurora
AU - Laghai, Iashar
AU - Laudicella, Riccardo
AU - Migliari, Silvia
AU - Orsini, Federica
AU - Pignata, Salvatore Antonio
AU - Popescu, Cristina E.
AU - Puta, Erinda
AU - Ricci, Martina
AU - Seghezzi, Silvia
AU - Sindoni, Alessandro
AU - Sollini, Martina
AU - Sturiale, Letterio
AU - Svyridenka, Anna
AU - Vergura, Vittoria
AU - Alongi, Pierpaolo
AU - Young AIMN Working Group, AIMN Working Group
PY - 2016/10/28
Y1 - 2016/10/28
N2 - AIM: To present the current state-of-the art of molecular imaging in the management of patients affected by inflammatory bowel disease (IBD).METHODS: A systematic review of the literature was performed in order to find important original articles on the role of molecular imaging in the management of patients affected by IBD. The search was updated until February 2016 and limited to articles in English.RESULTS: Fifty-five original articles were included in this review, highlighting the role of single photon emission tomography and positron emission tomography.CONCLUSION: To date, molecular imaging represents a useful tool to detect active disease in IBD. However, the available data need to be validated in prospective multicenter studies on larger patient samples.
AB - AIM: To present the current state-of-the art of molecular imaging in the management of patients affected by inflammatory bowel disease (IBD).METHODS: A systematic review of the literature was performed in order to find important original articles on the role of molecular imaging in the management of patients affected by IBD. The search was updated until February 2016 and limited to articles in English.RESULTS: Fifty-five original articles were included in this review, highlighting the role of single photon emission tomography and positron emission tomography.CONCLUSION: To date, molecular imaging represents a useful tool to detect active disease in IBD. However, the available data need to be validated in prospective multicenter studies on larger patient samples.
KW - Journal Article
U2 - 10.4329/wjr.v8.i10.829
DO - 10.4329/wjr.v8.i10.829
M3 - Article
C2 - 27843542
VL - 8
SP - 829
EP - 845
JO - World journal of radiology
JF - World journal of radiology
SN - 1949-8470
IS - 10
ER -